Treatment Access for Positive MSM in the Asia Pacific. APN+ (2011)
 |
In collaboration with various community-based organisations, APN+ conducted a peer-led mixed method research project in six Asian countries (India, Indonesia, Malaysia, Myanmar, Nepal, and Singapore) to document the range of services available for |
Mapping HIV Vulnerability along Kampong Thom, Siem Reap, Odor Meanchey and Preah Vihear, Cambodia. UNDP (2004)
 | The poor state of Cambodia’s infrastructure has posed a major obstacle to development and poverty reduction efforts. The Cambodian government has recognized this challenge and made infrastructure, especially road rehabilitation, one of its top priorities. The “Provincial and Rural Infrastructure Project (PRIP)”, 2003-2005, was jointly developed by the Cambodian Ministry of Public Work and Transport (MPWT), the Ministry of Rural Development (MRD), the Ministry of Economy and Finance (MEF) and the World Bank (WB). As part of this project, parts of Route six, which run through the four provinces of Kampong Thom, Siem Reap, Preah Vihear and Odor Meanchey, have been targeted for rehabilitation. Although this project is expected to reduce poverty, negative side effects are also expected, such as the increase in HIV vulnerability of roadside communities. It is therefore essential to identify populations that are most vulnerable to HIV infection, and develop ways to build their HIV resilience. Download this publication |
Expanding Access to HIV/AIDS Treatment: Mission Report Indonesia. WHO (2004)
| Recently, Indonesia has adopted an ambitious target of providing antiretroviral treatment (ART) to at least 10 000 people by the end of 2005. As of January 2004, of an estimated 15 000 people who were in need of ART, only 1300 persons were receiving the treatment. The intermediate target for 2005 is in line with the global WHO and UNAIDS "3 by 5" initiative. The initiative aims to provide three million people in developing countries (out of six million in need globally) access to ART by the end of 2005. The ultimate goal of the initiative is to provide universal access. Download this publication |
Handbook on Access to HIV/AIDS-Related Treatment. UNAIDS, WHO and Alliance (2003)
| The Handbook on access to HIV/AIDS-related treatment aims to build practical skills for nongovernmental organizations (NGOs), community-based organizations (CBOs) and groups of people living with HIV/AIDS (PLWHA) that are responding to HIV/AIDS in developing countries. It is a resource designed to help NGOs, CBOs and PLWHA groups to improve the quality of their work on HIV/AIDS-related treatment. Download this publication |
Expanding Access to HIV/AIDS Treatment: Mission Report India. WHO (2003)
| This report was prepared by a WHO team comprising members from WHO headquarters, the Regional Office for South-East Asia (SEARO), and the WHO Representative's Office (WRO) in collaboration with representatives from UNICEF and UNAIDS. The mission consulted development partners, stakeholders, nongovernmental organizations (NGOs) and civil society representatives. The dialogue on behalf of the Government of India was led by Mr JVR Prasada Rao, Secretary, Department of Health, and Mrs Meenakshi Datta Ghosh, Additional Secretary and Project Director, National AIDS Control Organization (NACO). The mission consulted Mr Ajay Seth, Director, Department of Economic Affairs, Ministry of Finance. The mission is grateful to the officials, partners and colleagues (see Annex 1) who participated or provided support and advice. The programme of the mission is at Annex 2. The WHO team would like to thank the Government of India for its assistance and gracious hospitality. Download this publication |
Organizational Mapping Project of HIV/AIDS Groups for MSM and Transgenders in Developed Asia. The Asia Pacific Coalition on Male Sexual Health (2010)
 |
HIV prevalence among MSM/TGs in countries (Hong Kong, Japan, Macau, South Korea, Singapore, and Taiwan)in Developed Asia is generally higher than the national figures. While public resources exist for combating HIV/AIDS, in the case of MSM/TGs in these countries, the lack of political leadership and social taboos against sexual minorities have curtailed preventive measures. |
Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All. International Treatment Preparedness Coalition (2007)
| At the G8 meeting in Gleneagles in 2005 and again at the United Nations UNGASS session in 2006, world leaders promised to come as close as possible to providing universal access to AIDS treatment and prevention by 2010. Estimates of HIV incidence and prevalence will change, but by any account, today several million people in desperate need of AIDS treatment do not have access to it. And at the current pace of growth in treatment delivery, several million will not have access by the end of 2010. Broken promises will mean millions of deaths. Download this publication |
HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan. Todd CS, Abed AMS, Strathdee SA, et al (2007)
| Limited prevalence data for HIV, hepatitis B surface an- tigen (HBsAg), and hepatitis C virus (HCV) exist for Afghan- istan. We studied a cross-sectional sample of adult injection drug users (IDUs) in Kabul, Afghanistan, from June 2005 through June 2006. Study participants completed interview- er-administered questionnaires and underwent testing for HIV, antibody to HCV, and HBsAg. Download this publication |
Access to HIV Treatment and Services for HIV positive MSM in 4 Chinese Cities. APN+ (2012)
 |
A community research training and consultation was held in Beijing from the 17th to 21st December 2010 among positive MSM community representatives from 4 Chinese cities: Beijing, Chengdu, Kunming, and Shanghai. The intention was to build upon a |
Programmatic Update: Antiretroviral Treatment as Prevention (TASP) of HIV and TB. WHO (2012)
 |
In 2010, an estimated 34 million people were living with the human immunodeficiency virus (HIV), around 70% of them in sub-Saharan Africa. By the end of 2010, 6.6 million people, or 47% of those in need (CD4+ cell count <350 cells/mm3), were on antiretroviral therapy (ART), and an estimated 7.5 million people were still in need of treatment. While considerable progress has been made in extending ART coverage, there continue to be critical gaps. In the same year, coverage for children was reported to be less than 23%, there were 2.7 million new infections and more than 20 million people were not yet treatment-eligible (as most of them did not know their HIV status). There were an estimated 1.1 million new cases of HIV-associated tuberculosis (TB), which led to 24% of HIV-related deaths. HIV is the strongest risk factor for developing TB, and people living with HIV have a 20–37 times higher risk of developing TB than those who do not. ART has a significant secondary prevention benefit for both HIV and TB, and expanded access to ART has probably averted millions of HIV infections and cases of TB. |
